Thanks, a lot of what you and Joboggi say seem to happen be happening or as sometimes stated not going to happen and though not always correct mostly spot on. I think being realistic is much more important when investing than falling in love with the company or always looking at it through rose colored glasses. Even the best plans go astray and things do not always go according to plan and things can get bad rather quickly or overtime but hopefully recover sometimes though they may not.
The products are so bad that's way the company has attracted big names to there BOD, BOA and SAB's. Give me a break!
LymPro results have been so bad that its being compared against PET, current gold standard test. Obviously you don't test a failing diagnostic test against the gold standard unless the results are good.
How exactly would another RS work with only 13 million OS?
Your information isn't even logical or pointing to anything specific.
Market Data 
Markets 
AI
